Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Feasibility of TachoSil Application on Esophageal Anastomoses
2011-005749-10Phase 3Active
- Sponsor
- University Medical Center Utrecht
- Start
- Jun 2012
- Modality
- Recombinant Proteins and Enzymes, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of tachosil in esophageal anastomotic leak and anastomotic dehiscence (AD), sponsored by University Medical Center Utrecht. Primary endpoint: Feasibility of TachoSil application on esophageal anastomoses. Started Jun 2012; status: active.
02
Drugs
tachosil
03
Conditions
esophageal anastomotic leakanastomotic dehiscence (AD)
Beyond the preview
Go deeper on 2011-005749-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005749-10.